| Drug Type Interleukins | 
| Synonyms Pulmoleukin | 
| Target | 
| Action stimulants | 
| Mechanism IL-2 stimulants(Interleukin-2 stimulants) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePhase 3 | 
| First Approval Date- | 
| Regulation- | 
| KEGG | Wiki | ATC | Drug Bank | 
|---|---|---|---|
| - | - | - | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Renal Cell Carcinoma | Phase 3 | - | - | 
| Not Applicable | 107 | xuqbdrfiih(dpvtgkvvfh) = 20.4% of weeks aumwgkxtvc (mylqczrmnl ) View more | Positive | 20 Jun 2006 | 






